Womens Health Therapeutics Market To 2018 – Unmet Need For Safe And Effective Treatments Due To Unfavorable Risk/Benefit Profile Associated With Hormone Replacement Therapy
“The Report Womens Health Therapeutics Market to 2018 – Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”
GBI Research, a leading business intelligence provider, has released its latest research, “Women’s Health Therapeutics Market to 2018 Unmet Need for Safe and Effective Treatments due to Unfavorable Risk/Benefit Profile Associated with Hormone Replacement Therapy”, which provides insights into the women’s health therapeutics market until 2018. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. It provides an in-depth analysis of the major diseases, and includes coverage of menopause, postmenopausal osteoporosis, endometriosis, infertility, and female contraceptives. The report provides in-depth analysis of the drivers and barriers that affect the global women’s health market, and analyzes the markets for women’s health disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also analyzes the women’s health therapeutics market in India, China and Australia. Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that have shaped the global market.
In 2011, the women’s health therapeutics market was estimated to be worth $18.8 billion. GBI Research forecasts the market to grow at a Compound Annual Growth Rate (CAGR) of 2.7% between 2011 and 2018, to record a sales value of $22.7 billion in 2018. The patent expiries of blockbusters such as Evista, the Premarin family, Forteo, Mirena, Boniva, Actonel, Gonal-F and others during the forecast period are expected to slow down the market growth for the women’s health therapeutics market. The launch of novel molecules like Elagolix and Odanacatib in the late stage pipeline will drive the market in the forecast period.
The women’s health therapeutics market R&D pipeline shows promising molecules. The current treatment options for women’s disorders are limited due to lack of safety. The unmet need in the women’s disorders market is attracting the pharmaceutical companies to invest in R&D programs. Increased focus is seen on therapy areas such as menopause, female sexual dysfunction and infertility.
Annualized market data for the women’s health disorders market from 2003 to 2011, with forecasts to 2018.
Analysis of the leading therapeutic segments, including menopause, postmenopausal osteoporosis, endometriosis, infertility, and the female contraceptives market.
Analysis of the women’s health therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
Market characterization of the women’s health therapeutics market, including market size, annual cost of therapy and treatment usage patterns.
Key drivers and barriers that have a significant impact on the market.
Coverage of pipeline molecules in various phases of drug development.
Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer Inc., Eli Lilly and Company, F. Hoffman-La Roche Ltd., Merck, Bayer and Warner Chilcott Plc.
Key M&A activities and licensing agreements that took place in the years 2010 to 2012 in the women’s health therapeutics market.
Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/149604
Reasons to buy
Align your product portfolio to the markets with high growth potential.
Develop market entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.
Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.
Develop key strategic initiatives by understanding the key focus areas of leading companies.
Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.
Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10
2 Women’s Health Therapeutics Market to 2018 – Introduction 12
2.1 Overview 12
3 Women’s Health Therapeutics Market to 2018 – Market Overview 13
3.1 Introduction 13
3.2 Revenue Forecasts for the Women’s Health Therapeutics Market 14
3.2.1 Revenues 14
3.2.2 Annual Cost of Therapy 15
3.2.3 Branded and Generic Market Share 16
3.3 Treatment Usage Patterns 17
3.4 Drivers and Barriers for the Women’s Health Therapeutics Market 19
3.4.1 Drivers for the Women’s Health Therapeutics Market 19
3.4.2 Barriers for the Women’s Health Therapeutics Market 19
4 Women’s Health Therapeutics Market to 2018 – Geographical Landscape 20
4.1 The US 20
4.1.1 Revenue 20
4.1.2 Annual Cost of Therapy 21
4.1.3 Treatment Usage Pattern 22
4.2 Top Five Countries of Europe 23
4.2.1 Revenue 23
4.2.2 Annual Cost of Therapy 25
4.2.3 Treatment Usage Pattern 26
4.3 Japan 27
4.3.1 Revenue 27
4.3.2 Annual Cost of Therapy 28
4.3.3 Treatment Usage Pattern 29
4.4 Women’s Health Therapeutics Market, Australia – Overview 30
4.4.1 Epidemiology 30
4.4.2 Clinical Trials 30
4.4.3 Drivers and Restraints 31
4.5 Women’s Health Therapeutics Market, India – Overview 31
4.5.1 Epidemiology 31
4.5.2 Clinical Trials 32
4.5.3 Drivers and Restraints 32
4.6 Women’s Health Therapeutics Market, China – Overview 33
4.6.1 Epidemiology 33
4.6.2 Clinical Trials 33
4.6.3 Drivers and Restraints 34
Browse all latest Press Releases of Market Research Reports
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Canada Toll Free: 866-997-4948